ELSEVIER Australia has published Neurology for General Practitioners – a compact but expansive clinical practice handbook by acclaimed neurologist and academic, Professor Ron Beran.
General Practitioners (GPs) are typically the first to see patients with the early signs and symptoms of neurological disorders such as epilepsy, Parkinson’s disease or stroke, and are subsequently the first to diagnose or refer them. A neurology text written expressly for GPs is therefore likely to be of enormous benefit.
Neurology for General Practitioners is structured around clinical management with chapters addressing history, examination, investigation and treatment. All content is backed by clinical examples and explanations.
The textbook also addresses the majority of common disorders encountered in general practice and features a wealth of information to assist in the management of ongoing complications at a primary care level.
Neurology for General Practitioners is a useful, highly-anticipated guide for primary health care physicians and family physicians. It is equally ideal for practitioners in rural or isolated areas, along with neurology trainees.
Find out more about Neurology for General Practitioners.
About the author
Roy Beran MBBS, MD, FRACP, FRACGP, Grad Dip Tertiary Ed, Grad Dip Further Ed, FAFPHM, FACLM, FRCP, FACBS, B Leg S, MHL and FFFLM (Hon)
Roy Beran is Neurologist and Conjoint Professor at the University of New South Wales, NSW, and a Professor at Griffith University’s School of Medicine in Queensland, Australia.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).http://www.elsevierhealth.com.au
Annabel DentP: (+61) 02 9422 8554